Giant cell bone lesions in the craniofacial region: a diagnostic and therapeutic challenge
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
BORGES, Bruno Barros Pinto
BEZERRA, Ana Paula Correia de Araujo
Citação
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, v.2, n.6, p.501-506, 2012
Resumo
Background: Giant cell tumors of bone (GCTs) are common in the long bones, but rare in the craniofacial region, with only 1% of cases occurring in the latter. Clinical, radiological, and anatomical diagnosis of this locally aggressive disease, which occurs in response to trauma or neoplastic transformation, poses a major challenge in clinical practice. Methods: The present study describes a series of 4 cases and highlights the main features of the differential diagnosis and treatment of these lesions: GCT, giant cell reparative granuloma (GCRG), and the brown tumor of hyperparathyroidism. Results: GCT presents as a benign neoplasm, most typically affecting the knees, and rarely in the temporal and sphenoid bones. It is radiologically indistinguishable from GCRG due to its lytic, poorly defined appearance. The distinction can only be made microscopically, as the presence of multinucleated giant cells scattered throughout the stroma and the absence of a history of trauma favor a diagnosis of GCT. The brown tumor of hyperparathyroidism occurs with rapid, localized osteoclast activity secondary to the effects of increased parathyroid hormone (PTH) levels; parathyroid examination is indispensable. Conclusion: The diagnosis and treatment of these lesions poses a major challenge due to their similar clinical presentation and radiological appearance. Accurate diagnosis is essential for definition of appropriate management, as complete resection is the goal in GCT and GCRG to avoid recurrence, whereas the brown tumor often yields to treatment of the underlying hyperparathyroidism.
Palavras-chave
giant cell tumors, giant cell granuloma, brown tumor, craniofacial region, bone neoplasms
Referências
- Bilodeau Elizabeth, 2009, Head Neck Pathol, V3, P174, DOI 10.1007/s12105-009-0119-0
- Company MM, 2009, ARCH NEUROL-CHICAGO, V66, P134, DOI 10.1001/archneurol.2008.509
- Gandara-Rey Jose Manuel, 2002, Med Oral, V7, P254
- Leal Christianne T S, 2006, Arq Bras Endocrinol Metabol, V50, P963
- Marioni G, 2006, ACTA OTO-LARYNGOL, V126, P779, DOI 10.1080/00016480500504200
- Matsui T, 2002, NEUROL MED-CHIR, V42, P232, DOI 10.2176/nmc.42.232
- Mohammed TL, 2001, AM J NEURORADIOL, V22, P873
- Orhan E, 2010, INT J PEDIATR OTORHI, V74, P547, DOI [10.1016/j.ijporl.2010.02.006, 10.1016/j.ijpor1.2010.02.006]
- Proimos Efklidis, 2009, J Med Case Rep, V3, P7495, DOI 10.4076/1752-1947-3-7495
- Saw S, 2009, PATHOL ONCOL RES, V15, P291, DOI 10.1007/s12253-008-9124-y
- Triantafillidou K, 2006, AM J OTOLARYNG, V27, P281, DOI 10.1016/j.amjoto.2005.11.004
- WOLFE JT, 1983, J NEUROSURG, V59, P322, DOI 10.3171/jns.1983.59.2.0322